Mucoactive therapy in community-acquired pneumonia
Aim. To study the clinical efficacy of Bronchipret syrup compared with the standard (real-world practice) mucoactive therapy for patients with viral pneumonia. Materials and methods. The observation study included patients 1870 years old who presented with productive cough and were admitted to the p...
Saved in:
Main Authors: | Andrey A. Zaytsev (Author), Ekaterina A. Filon (Author) |
---|---|
Format: | Book |
Published: |
ZAO "Consilium Medicum",
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucocorticosteroids for community-acquired pneumonia (execution cannot be pardoned): A review
by: Andrey A. Zaytsev
Published: (2024) -
Community-acquired pneumonia: antibiotic therapy approach after the COVID-19 pandemic. A review
by: Andrey A. Zaytsev, et al.
Published: (2023) -
Modern aspects of the choice of mucoactive cough therapy in pediatric practice
by: L.V. Besh, et al.
Published: (2018) -
Antibacterial therapy of community-acquired pneumonia in children
by: A.E. Abaturov, et al.
Published: (2018) -
Sequential Therapy of Community-Acquired Pneumonia in Children
by: I.A. Karimdzhanov, et al.
Published: (2014)